<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">influenza </span>
   <span class="font30">virus </span>
   <span class="font25">(). </span>
   <span class="font25">CHLA </span>
   <span class="font23">CHLI </span>
   <span class="font20">IAV </span>
   <span class="font17">cells </span>
   <span class="font17">{border-style </span>
   <span class="font16">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">antiviral </span>
   <span class="font16">acid </span>
   <span class="font16">inhibitors </span>
   <span class="font16">natural </span>
   <span class="font16">neuraminidase </span>
   <span class="font15">viral </span>
   <span class="font15">MDCK </span>
   <span class="font15">activity </span>
   <span class="font15">chebula </span>
   <span class="font15">pods </span>
   <span class="font15">reporter </span>
   <span class="font15">samples </span>
   <span class="font14">product </span>
   <span class="font14">infected </span>
   <span class="font14">inhibition </span>
   <span class="font14">novel </span>
   <span class="font14">ripe </span>
   <span class="font14">viruses </span>
   <span class="font13">infection </span>
   <span class="font13">oseltamivir </span>
   <span class="font13">presence </span>
   <span class="font13">release </span>
   <span class="font13">unripe </span>
   <span class="font13">(Figure </span>
   <span class="font13">-well </span>
   <span class="font13">Influenza </span>
   <span class="font13">PR-PB-Gluc </span>
   <span class="font13">United </span>
   <span class="font13">assay </span>
   <span class="font13">inhibitor </span>
   <span class="font13">replication </span>
   <span class="font13">showed </span>
   <span class="font13">using </span>
   <span class="font13">Shandong </span>
   <span class="font13">culture </span>
   <span class="font13">experiments. </span>
   <span class="font13">plates </span>
   <span class="font13">progeny </span>
   <span class="font13">px; </span>
   <span class="font13">resistance </span>
   <span class="font13">{font-family </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">Assay </span>
   <span class="font12">Chinese </span>
   <span class="font12">Data </span>
   <span class="font12">MOI </span>
   <span class="font12">assay. </span>
   <span class="font12">chebulagic </span>
   <span class="font12">font-size </span>
   <span class="font12">group </span>
   <span class="font12">target </span>
   <span class="font12">test </span>
   <span class="font12">(A) </span>
   <span class="font12">(B) </span>
   <span class="font12">-cavity </span>
   <span class="font12">Briefly, </span>
   <span class="font12">Drug </span>
   <span class="font12">FIGURE </span>
   <span class="font12">However, </span>
   <span class="font12">RNA </span>
   <span class="font12">absence </span>
   <span class="font12">action </span>
   <span class="font12">anti-IAV </span>
   <span class="font12">chebulinic </span>
   <span class="font12">compounds </span>
   <span class="font12">concentrations </span>
   <span class="font12">containing </span>
   <span class="font12">cytotoxicity </span>
   <span class="font12">different </span>
   <span class="font12">double; </span>
   <span class="font12">drug </span>
   <span class="font12">entry </span>
   <span class="font12">independent </span>
   <span class="font12">luciferase </span>
   <span class="font12">medium </span>
   <span class="font12">new </span>
   <span class="font12">performed </span>
   <span class="font12">potent </span>
   <span class="font12">screening </span>
   <span class="font12">strains </span>
   <span class="font12">Î¼g/mL </span>
   <span class="font11">(Grant </span>
   <span class="font11">CHLI, </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Neuraminidase </span>
   <span class="font11">No. </span>
   <span class="font11">University </span>
   <span class="font11">activity. </span>
   <span class="font11">antivirals </span>
   <span class="font11">article </span>
   <span class="font11">baloxavir </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">data </span>
   <span class="font11">doseâ€"response </span>
   <span class="font11">hit </span>
   <span class="font11">identified </span>
   <span class="font11">means </span>
   <span class="font11">oseltamivir-resistant </span>
   <span class="font11">phenotypic </span>
   <span class="font11">solid; </span>
   <span class="font11">supernatants </span>
   <span class="font11">targeting </span>
   <span class="font11">treatment </span>
   <span class="font11">various </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">(Zhao </span>
   <span class="font11">./s--- </span>
   <span class="font11">./v </span>
   <span class="font11">Figure </span>
   <span class="font11">Infect. </span>
   <span class="font11">Inhibit </span>
   <span class="font11">Inhibition </span>
   <span class="font11">NA/HY </span>
   <span class="font11">NAs </span>
   <span class="font11">Opti-MEM </span>
   <span class="font11">Research </span>
   <span class="font11">States). </span>
   <span class="font11">Traditional </span>
   <span class="font11">Viral </span>
   <span class="font11">Wang, </span>
   <span class="font11">active </span>
   <span class="font11">activities </span>
   <span class="font11">approach </span>
   <span class="font11">based </span>
   <span class="font11">binding </span>
   <span class="font11">bold </span>
   <span class="font11">concentration </span>
   <span class="font11">courier; </span>
   <span class="font11">derivatives </span>
   <span class="font11">described </span>
   <span class="font11">drugs </span>
   <span class="font11">em; </span>
   <span class="font11">inhibit </span>
   <span class="font11">inhibitory </span>
   <span class="font11">major </span>
   <span class="font11">mechanism </span>
   <span class="font11">mechanisms </span>
   <span class="font11">polymerase </span>
   <span class="font11">potential </span>
   <span class="font11">previously </span>
   <span class="font11">provided </span>
   <span class="font11">pt;} </span>
   <span class="font11">release. </span>
   <span class="font11">replication. </span>
   <span class="font11">results </span>
   <span class="font11">suggesting </span>
   <span class="font11">used </span>
   <span class="font11">vaccines </span>
   <span class="font11">vitro </span>
  </p>
 </body>
</html>
